ASLAN Pharmaceuticals Ltd (ASLN) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER...

Securities Registration (ads, Immediate) (f-6ef)

  As filed with the U.S. Securities and Exchange Commission on April 26, 2023   Registration No. 333...

Small Company Offering and Sale of Securities Without Registration (d)

 UNITED STATES SECURITIESAND EXCHANGE COMMISSIONWashington, D.C.FORM DOMB APPROVALOMB Number: 3235-0076Estimated Average burden hours per...

Annual and Transition Report (foreign Private Issuer) (20-f)

0March 31, 201800017229260000true0false0December 31, 201500FY--12-310000001722926asln:OrdinarySurplusMember202...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...